54 results
Page 2 of 3
8-K
EX-99.1
ddy4cz6 f5
29 Jun 21
Cerevel Therapeutics Announces Positive Topline Results for CVL-231 in Phase 1b
6:52am
DRS
itts37pefsqlwpha b8r
27 May 21
Draft registration statement
12:00am
DEF 14A
jg2redvcn2d xtwf3d
28 Apr 21
Definitive proxy
4:13pm
8-K
EX-10.1
qjj2ou 7jhfxgqwkz2cd
21 Apr 21
Cerevel Therapeutics Appoints Abraham N. Ceesay as President
4:07pm
424B3
5cbw7y91ndg6gq3yd
26 Mar 21
Prospectus supplement
4:31pm
POS AM
iviwbxwmrmu9m7f4crn
24 Mar 21
Prospectus update (post-effective amendment)
5:13pm
10-K
EX-3.2
rxdmb7i
24 Mar 21
Annual report
4:20pm
10-K
ez74o
24 Mar 21
Annual report
4:20pm
10-K
EX-2.1
dqismydzy0w
24 Mar 21
Annual report
4:20pm
424B3
gtqebegk6
4 Dec 20
Prospectus supplement
4:58pm
8-K
EX-10.12
ndj1f vpytp
2 Nov 20
Entry into a Material Definitive Agreement
4:30pm
8-K
EX-10.14
iem yfpd844
2 Nov 20
Entry into a Material Definitive Agreement
4:30pm